While most of Flagship’s customers are at biotech and pharma locations around the world, there has been some strong collaborations formed with Arizona biotech firms. “The collaboration spirit in Arizonais remarkable” said Steve Potts. “the amount of additional business that Arizona groups like TGEN generate for other local biotech providers is astonishing. It has been an honor to work with Steve Gately’s TGEN Drug Development group (TD2), with a number of completed projects where TD2 applies their unique oncology expertise and Flagship adds our quantitative pathology.”

Arizona has a number of worldclass specialty contract research organizations, including TD2 in Oncology, Flagship Biosciences in pathology, Imaging Endpoints in radiology, Medelis in oncology and dermatology clinical trials, and SDC in statistics. The need for best-in-class specialty service is growing in the pharmaceutical industry, and Arizona with a skilled workforce, strong collaborative spirit, and industry friendly environment is positioned to lead in this area.

Efficient Data Management: One Way to Expedite the Clinical Development Proces

Debates on the safety and effectiveness of vaccines have captured the public’s attention recently. A vaccine is a preventative strategy for certain...

Read more +

The Clinical Trial Process Continues Amid COVID-19

It’s no secret that the top health concern on most Americans’ minds today is COVID-19 – a unprecedented disrupter like we’ve never seen...

Read more +

Technology Challenges and Trends in Clinical Trials

Cancer remains a leading cause of death among Americans with nearly two million newly diagnosed patients in 2018. As this trend continues, various...

Read more +

GET STARTED

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.